Wow..>>>How Teva expects to get around GILD’s patent on Viread, the other constituent of Truvada, is unclear.<<<
Dew, Teva always does all their DD, inside and out and this one will be a dogfight imho....two powerhouses presenting the science, the patents, clinical trial data, in a high stakes game in court....wow.
Market Data 
Markets 
AI
